$35.24
Price
$4.0B
Market Cap
—
P/E Ratio
-20.5
Forward P/E
$-2.04
EPS (TTM)
—
Dividend Yield
$703M
Cash
$448000
Total Debt
113M
Shares Out
$14.06
$42.00
52-Week Range
Institutional Ownership of NEWAMSTERDAM PHARMA COMPANY
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for NEWAMSTERDAM PHARMA COMPANY
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| SELL | -7.2% | 6.5M | $184M | $24.32 | |
| 2024-Q4 | |||||
| SELL | -13.0% | 7.0M | $179M | $19.85 | |
| 2023-Q3 | |||||
| BUY | +23.0% | 8.0M | $74M | $10.90 | |
| 2023-Q2 | |||||
| BUY | +66.6% | 6.5M | $78M | $13.52 | |
| 2023-Q1 | |||||
| BUY | +4.3% | 3.9M | $53M | $13.00 | |
| 2022-Q4 | |||||
| BUY | NEW | 3.8M | $39M | $10.00 | |
Insider Trading for NEWAMSTERDAM PHARMA COMPANY
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.